ArticleIJID regions2026
Maternal preparedness for uptake of newborn hepatitis B immunoprophylaxis at birth: Implications for preventing mother-to-child transmission in resource-limited settings.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Hepatitis B virus (HBV) remains a major public health challenge in sub-Saharan Africa, with mother-to-child transmission (MTCT) being the dominant route of infection. Timely administration of combined immunoprophylaxis HBV vaccine and hepatitis B immunoglobulin within 24 hours of birth is critical for prevention. However, maternal readiness to facilitate this intervention is poorly documented in Ghana. The study aimed to assess maternal preparedness for uptake of HBV immunoprophylaxis for exposed newborns in Northern Ghana and to identify associated predictors. Methods: A cross-sectional study was conducted among 118 hepatitis B surface antigen-positive pregnant women attending antenatal care in 10 health facilities. Data were collected using a structured 10-item preparedness scale (α >0.70) and analyzed using SPSS v23. Descriptive statistics, chi-square tests, analysis of variance and multivariable logistic regression were applied to identify differences in preparedness scores across variables and predictors of preparedness. Results: The mean preparedness score was 3.29 (SD = 0.70) reflecting an overall response between 'agree' and 'strongly agree' on the 5-point Likert scale. Based on percentage scores derived from the composite preparedness scale, 72% of women demonstrated high preparedness, while 28% were moderately prepared. None had poor preparedness. Preparedness was highest for perceived importance of immunoprophylaxis (M = 3.81) and knowledge of MTCT (M = 3.70). Lower mean scores were observed for financial readiness (M = 2.36) and adequacy of information from health providers (M = 2.57). Preparedness varied significantly by income category ( Conclusions: Maternal preparedness for HBV immunoprophylaxis in Northern Ghana was high, reflecting good awareness of MTCT prevention. However, financial constraints and insufficient provider information remain key barriers. Income-related differences highlight the need for cost-reduction strategies, while the negative association with tertiary education warrants further investigation. Strengthening antenatal counseling and integrating hepatitis B immunoglobulin into national financing schemes could improve equitable uptake and support HBV MTCT elimination efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.